| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 2,799,528 | 2,615,101 | 2,887,400 | 3,382,509 | | Cost of Revenue | 2,608,561 | 2,466,512 | 2,731,854 | 3,158,796 | | | Gross Profit | 190,967 | 148,589 | 155,546 | 223,713 | | | Operating Expenses | | Research Development | 8,714 | 7,198 | 5,754 | 5,655 | | Selling General and Administrative | 127,807 | 125,419 | 111,053 | 131,662 | | Non Recurring | 3,582 | 16,167 | 736,645 | 318,321 | | Others | 7,719 | 7,612 | 7,673 | 8,035 | | | | Total Operating Expenses | 147,822 | 156,396 | 861,125 | 463,673 | | | | Operating Income or Loss | 43,145 | (7,807) | (705,579) | (239,960) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (13,830) | 139 | 1,063 | (57) | | Earnings Before Interest And Taxes | 29,315 | (7,668) | (704,516) | (240,017) | | Interest Expense | 19,393 | 19,043 | 20,077 | 23,734 | | Income Before Tax | 9,922 | (26,711) | (724,593) | (263,751) | | Income Tax Expense | 3,989 | 2,528 | 142,018 | 12,363 | | Minority Interest | (426) | 477 | 511 | 257 | | | | Net Income From Continuing Ops | 5,507 | (28,762) | (866,100) | (275,857) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,507 | (28,762) | (866,100) | (275,857) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,507 | ($28,762) | ($866,100) | ($275,857) |
|
0.34% Nasdaq 
0.03 (0.22%) 
Income Statement
